SMARCA4 and neoplasm: These tumor have a distinctive IHC profile (loss of SMARCA4/BRG1, loss of SMARCA2/BRM, and expression of stem-cell markers SALL4, CD34, SOX2), although SOX2 is also commonly positive in NECs.